Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Diseases: Page 2
Protein biomarker may aid in early Parkinsonian disorders detection
A protein biomarker present in cerebrospinal fluid and blood plasma may be useful for the early diagnosis of Parkinsonian disorders.
September 21, 2023
Day Zero Diagnostics completes $16M financing round
Day Zero Diagnostics has completed a $16 million financing round, executed as a convertible note.
September 20, 2023
Researchers develop signature for scoring thyroid cancers
A team led by researchers at Vanderbilt University Medical Center has developed a signature for thyroid cancer aggressiveness that incorporates immune and other microenvironment features through multiomic analyses.
September 20, 2023
NIH starts early-phase trial of second-generation universal flu vaccine candidate
The U.S. National Institutes of Health (NIH) has begun an early-phase clinical trial of its second-generation universal flu vaccine candidate.
September 20, 2023
NIHās systematic review finds AI may improve detection of underdiagnosed condition
A systematic review of earlier studies has found that artificial intelligence (AI) and machine learning (ML) can support the diagnosis of polycystic ovarian syndrome (PCOS).
September 19, 2023
Myriad Genetics, Memorial Sloan Kettering collaborate on MRD testing for breast cancer
Myriad Genetics is collaborating with Memorial Sloan Kettering Cancer Center to study the use of Myriad's minimal residual disease testing platform in predicting breast cancer treatment response.
September 18, 2023
African research consortium awarded $5.3M by EU Horizon Europe program to combat epidemics
A research consortium led by Stellenbosch University in Stellenbosch, South Africa, was awarded 5 million euros ($5.3 million) from the EU Horizon Europe program for genomic research in combating epidemics in Africa.
September 18, 2023
Modernaās mRNA flu shot yields promising results in phase III trial
Moderna announced that its mRNA flu shot that is in development has met its primary endpoints in a phase III trial, generating a stronger immune response than a commercially available flu vaccine.
September 15, 2023
Experts raise concerns about Quest Diagnosticsā consumer-initiated Alzheimerās test
Experts have raised concerns about Quest Diagnosticsā $399 consumer-initiated Alzheimerās disease test, telling 360Dx that it is unclear whether the product is accurate enough to support its use.
September 15, 2023
Report: Lack of standardization a āhugeā issue during pandemic, problems persist
A lack of standardization of infectious disease consumables was āa huge, unanticipated issue during the pandemicā that still needs to be resolved, according to a report in GenomeWeb.
September 15, 2023
U.K. charity to offer $1.6M in grants for research on muscle-wasting diseases
U.K. research projects will benefit from 1.3 million pounds ($1.6 million) in grants to improve diagnostic testing and potential new treatments for muscle-wasting and -weakening conditions.
September 14, 2023
Whistleblower claims CIA analysts were bribed to reject COVID-19 'lab leak' origin hypothesis
A whistleblower gave testimony to two panels of the House of Representatives alleging that six CIA analysts were bribed to reject the theory that the COVID-19 pandemic resulted from a research-related leak of a new coronavirus.
September 15, 2023
Previous Page
Page 2 of 271
Next Page